Experience with the use of an investigational F(ab')2 heptavalent botulism immune globulin of equine origin during an outbreak of type E botulism in Egypt

Clicks: 321
ID: 271184
1996
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Star

Ranked #152 of 588 articles by views in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 588 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
During an outbreak of type E foodborne botulism in Cairo in 1991, an investigational equine F(ab')2 "despeciated" heptavalent botulism immune globulin (dBIG) was provided to the Egyptian Ministry of Health by the U.S. Army. Of 54 patients known to have been treated with antitoxins, 4 received commer …
Reference Key
rg1996clinicalexperience Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Hibbs RG;Weber JT;Corwin A;Allos BM;Abd el Rehim MS;Sharkawy SE;Sarn JE;McKee KT;;
Journal Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Year 1996
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/8842274
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support u.s. gov't non-p.h.s. disease outbreaks interviews as topic botulism / drug therapy* botulinum toxins / immunology* botulism / epidemiology pmid:8842274 doi:10.1093/clinids/23.2.337 r g hibbs j t weber k t mckee antitoxins / adverse effects* clostridium botulinum / immunology* egypt / epidemiology globulins / immunology immunoglobulin fab fragments / adverse effects* immunoglobulin fab fragments / therapeutic use

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.